Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference23 articles.
1. Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Davies;Diabetes Care,2018
2. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
3. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2019
4. Dapagliflozin in patients with chronic kidney disease;Heerspink;N Engl J Med,2020
5. Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors;Rosenstock;Diabetes Care,2015